Open Tender for Inj Dexmedetomidine 100 mcg oblic ml 50 ml vial,Diethyl Ether Solvent Bott of 500 ml,Ketamine HCl 5 in WEST KAMENG, ARUNACHAL PRADESH
Bid Publish Date
30-Apr-2025, 1:09 pm
Bid End Date
22-May-2025, 2:00 pm
EMD
₹22
Value
₹16,60,738
Location
Progress
RAQuantity
10450
Bid Type
Two Packet Bid
Categories
27
A tender has been published for Indian Army Inj Dexmedetomidine 100 mcg oblic ml 50 ml vial, Diethyl Ether Solvent Bott of 500 ml, Ketamine HCl 5 in WEST KAMENG, ARUNACHAL PRADESH. Quantity: 10450 by. Submission Deadline: 22-05-2025 14: 00: 00. Check eligibility and apply.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7751620.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
91 Items Sign in to view GEM price trends Sign in for GEM prices
Inj Dexmedetomidine 100 mcg oblic ml 50 ml vial
as per title
Diethyl Ether Solvent Bott of 500 ml
as per title
Ketamine HCl 50 mg oblicml 2 ml Inj
as per title
Thiopentone Inj of 0 point5 g without water for Injection
as per title
Lignocaine 2 percent contain Lignocaine 21 point 3 mg Methyl 100ml
as per title
Inj Lignocaine 2 percent without Adrenaline 30 ml suitable ophthalmic use also
as per title
Lignocaine HCl 2 percent with Adrenaline 1 isto 80000 30 ml Inj
as per title
Inj Pentazocine Lactate 30 mg oblicml 1 ml Amp
as per title
Piroxicam 40 mg 2 ml inj
as per title
Morphine 15 mg 1 ml Inj
as per title
Pethedine 50 mg 1 ml Inj
as per title
Dexamethasone 4 point 4 mg Dexamethasone Phosphate 4 mg obli cml 2 ml Inj
as per title
Pralidoxime 500 mg oblic 20 ml Inj
as per title
Levetiracetam 100 mg oblicml Inj vial of 5 ml
as per title
Lorazepam 2 mg oblicml 2 ml Inj
as per title
Inj Phenytoin Sodium 100 mg
as per title
Dulaglutide 0 point 75 mg solution for Inj in pre filled pen
as per title
Inj Cefotaxime Sodium 250 mg Vial
as per title
Inj Amikacin IP 100 mg oblic2 ml Vial
as per title
Inj Amoxycillin 500 mg plus clavulanic acid 100 mg 600 mg vial
as per title
Inj Cefoperazone 500 mg plus Sulbactum 500 mg Vial
as per title
Inj Ceftazidime 500 mg Vial
as per title
Inj Ceftriaxone 500 mg Vial
as per title
Ceftriaxone 1000 mg plus Sulbactum 500 mg Inj Vial
as per title
Inj Benzathine Penicillin 12 00 000 IpointUpoint Vial
as per title
Inj Cefotaxime Sodium 250 mg plus Sulbactam 125 mg Vial
as per title
Inj Cefotaxime Sodium 500 mg plus Sulbactam 250 mg Inj Vial
as per title
Inj Cefotaxime Sodium 1000 mg plus Sulbactam 500 mg Inj Vial
as per title
Anti D 300 mcg Inj Vial of 02 ml
as per title
Tranexamic Acid 500 mg oblic5ml Inj
as per title
Phytomenadione Vit K 1 mg oblic 0 point5 ml Inj
as per title
Diltiazem 5mg oblicml Inj
as per title
Adenosine 3 mg oblicml 10 ml Inj
as per title
Digoxin 0point5 mg 2 ml Inj
as per title
Dobutamine HCl 250 mg 5 ml Inj
as per title
Labetalol HCl 5mg oblicml 4ml Inj
as per title
Terlipressin 1mg plus 10ml diluent or 0point10mg oblicml 10 ml vial oblic Amp
as per title
Octreotide 0 point1 mg oblic ml Inj
as per title
Polidocanol 3 percent 2ml Inj
as per title
Ranitidine HCl 50 mg 2 ml Inj
as per title
Dicyclomine HCl 20mg Inj
as per title
Hyoscine Bromide Inj 20 mg oblicml 1ml Inj
as per title
Dinoprostone Gel 0point5mg in 3gm oblic2point5ml gel oblicSyringe
as per title
Inj Human Insulin Analogue Rapid 100 IU Disposable Pen with 5 needles
as per title
Human Chorionic Gonadotrophin 2000 IU Inj
as per title
Pancuronium bromide 2 mg oblicml 2 ml Inj
as per title
Lignocaine 1 percent for intra-ocular use vial of 1 ml preservative free
as per title
Lignocaine Hyrochloride 4 percent topical solution bott of 30 ml
as per title
Natural Surfactanat 25 oblic80mg oblicml Inj
as per title
Haloperidol 5mg oblicml Inj
as per title
Dextrose 50 percent 25 ml Inj
as per title
Dextrose Inj 25 percent 25 ml Inj
as per title
Sodium Bicarbonate 7point5 percent amp of 10 ml
as per title
Meropenem 1 gm Inj
as per title
Vit B 12 500 mcg oblicml Inj
as per title
Multi Vit Inj IV 210 ml with minimum Thiamine B1 30mg Pyridoxine B6 30 mg ml
as per title
Dulaglutide 1point5 mg oblicml 0point5 ml PFS
as per title
Human Insulin Analogue Glargine Recombinant DNA origin 450 IU oblic1 point5 pen
as per title
Pheniramine Maleate 22point75 mg per ml Inj vial of 10 ml
as per title
Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj
as per title
Ampicillin 500 mg Inj
as per title
Benzyl penicillin 5 00 000 units inj
as per title
Amikacin Sulphate 250 mg oblic2 ml Inj
as per title
Cefoperazone Sodium 1 gm Inj
as per title
Inj Cefipime 1 mg
as per title
Ceftazidime 1 gm Inj
as per title
Ceftriaxone 1 gm Inj
as per title
Cefuroxime 750 mg oblicVial Inj
as per title
Ticarcillin 3g plus Clavulanic Acid 100 mg Inj
as per title
Meropenem 500 mg Inj
as per title
Doxycycline Inj vial of 10 ml
as per title
Tropnin T test card
as per title
BCG Vaccine
as per title
Hepatitis B Human Immunoglobulin HBIG
as per title
Tetanus Human Immunoglobulin
as per title
Typhoid vi conjugate vaccine 2 point 5 ml
as per title
Cell culture rabies vaccine vial
as per title
Japanese Encephalitis Vaccine 0 point 5 ml
as per title
Tetanus Toxoid purified absorbed Vial of 5 ml 10 Doses
as per title
Human Rabies Immune Globulin 150 IU oblicml 2 ml Vial
as per title
Rabies Vaccine Vial of 1 ml
as per title
Anti D RHO Immunoglobulin Monoclonal Human vial of 300 oblic 350 mcg
as per title
Dantrolene Sodium 250 mg per Vial Inj
as per title
Inj Mephenteramine 10ml
as per title
Inj Ropivacaine hcl in dextrose 0 point 75 percent Amp of 4 ml
as per title
Mumps measles rubella vaccine MMR
as per title
Live Attenuated Hepatitis A Vaccine
as per title
Diptheria Tetanus and Acellular pertusis DTaP vaccine
as per title
Lignocaine HCL SOL 2 percent IV 50ML
as per title
Inj Naloxone 4 mg per 10 ML
as per title
Inj Xylocard 2 pecent of 50 ML
as per title
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj Dexmedetomidine 100 mcg oblic ml 50 ml vial | as per title | 30 | amp | vibhu@181 | 21 | |
| 2 | Diethyl Ether Solvent Bott of 500 ml | as per title | 30 | bott | vibhu@181 | 21 | |
| 3 | Ketamine HCl 50 mg oblicml 2 ml Inj | as per title | 79 | ampvial | vibhu@181 | 21 | |
| 4 | Thiopentone Inj of 0 point5 g without water for Injection | as per title | 15 | ampvial | vibhu@181 | 21 | |
| 5 | Lignocaine 2 percent contain Lignocaine 21 point 3 mg Methyl 100ml | as per title | 6 | bott | vibhu@181 | 21 | |
| 6 | Inj Lignocaine 2 percent without Adrenaline 30 ml suitable ophthalmic use also | as per title | 40 | ampvial | vibhu@181 | 21 | |
| 7 | Lignocaine HCl 2 percent with Adrenaline 1 isto 80000 30 ml Inj | as per title | 48 | ampvial | vibhu@181 | 21 | |
| 8 | Inj Pentazocine Lactate 30 mg oblicml 1 ml Amp | as per title | 30 | amp | vibhu@181 | 21 | |
| 9 | Piroxicam 40 mg 2 ml inj | as per title | 30 | amp vial | vibhu@181 | 21 | |
| 10 | Morphine 15 mg 1 ml Inj | as per title | 126 | ampvial | vibhu@181 | 21 | |
| 11 | Pethedine 50 mg 1 ml Inj | as per title | 108 | ampvial | vibhu@181 | 21 | |
| 12 | Dexamethasone 4 point 4 mg Dexamethasone Phosphate 4 mg obli cml 2 ml Inj | as per title | 362 | ampvial | vibhu@181 | 21 | |
| 13 | Pralidoxime 500 mg oblic 20 ml Inj | as per title | 30 | no | vibhu@181 | 21 | |
| 14 | Levetiracetam 100 mg oblicml Inj vial of 5 ml | as per title | 210 | vial | vibhu@181 | 21 | |
| 15 | Lorazepam 2 mg oblicml 2 ml Inj | as per title | 378 | ampvial | vibhu@181 | 21 | |
| 16 | Inj Phenytoin Sodium 100 mg | as per title | 75 | amp | vibhu@181 | 21 | |
| 17 | Dulaglutide 0 point 75 mg solution for Inj in pre filled pen | as per title | 18 | pfp | vibhu@181 | 21 | |
| 18 | Inj Cefotaxime Sodium 250 mg Vial | as per title | 600 | vial | vibhu@181 | 21 | |
| 19 | Inj Amikacin IP 100 mg oblic2 ml Vial | as per title | 180 | vial | vibhu@181 | 21 | |
| 20 | Inj Amoxycillin 500 mg plus clavulanic acid 100 mg 600 mg vial | as per title | 60 | vial | vibhu@181 | 21 | |
| 21 | Inj Cefoperazone 500 mg plus Sulbactum 500 mg Vial | as per title | 50 | vial | vibhu@181 | 21 | |
| 22 | Inj Ceftazidime 500 mg Vial | as per title | 50 | vial | vibhu@181 | 21 | |
| 23 | Inj Ceftriaxone 500 mg Vial | as per title | 132 | vial | vibhu@181 | 21 | |
| 24 | Ceftriaxone 1000 mg plus Sulbactum 500 mg Inj Vial | as per title | 144 | vial | vibhu@181 | 21 | |
| 25 | Inj Benzathine Penicillin 12 00 000 IpointUpoint Vial | as per title | 6 | vial | vibhu@181 | 21 | |
| 26 | Inj Cefotaxime Sodium 250 mg plus Sulbactam 125 mg Vial | as per title | 60 | vial | vibhu@181 | 21 | |
| 27 | Inj Cefotaxime Sodium 500 mg plus Sulbactam 250 mg Inj Vial | as per title | 60 | vial | vibhu@181 | 21 | |
| 28 | Inj Cefotaxime Sodium 1000 mg plus Sulbactam 500 mg Inj Vial | as per title | 120 | vial | vibhu@181 | 21 | |
| 29 | Anti D 300 mcg Inj Vial of 02 ml | as per title | 12 | vial | vibhu@181 | 21 | |
| 30 | Tranexamic Acid 500 mg oblic5ml Inj | as per title | 50 | ampvial | vibhu@181 | 21 | |
| 31 | Phytomenadione Vit K 1 mg oblic 0 point5 ml Inj | as per title | 100 | ampvial | vibhu@181 | 21 | |
| 32 | Diltiazem 5mg oblicml Inj | as per title | 20 | ampvial | vibhu@181 | 21 | |
| 33 | Adenosine 3 mg oblicml 10 ml Inj | as per title | 48 | ampvial | vibhu@181 | 21 | |
| 34 | Digoxin 0point5 mg 2 ml Inj | as per title | 12 | ampvial | vibhu@181 | 21 | |
| 35 | Dobutamine HCl 250 mg 5 ml Inj | as per title | 118 | ampvial | vibhu@181 | 21 | |
| 36 | Labetalol HCl 5mg oblicml 4ml Inj | as per title | 66 | ampvial | vibhu@181 | 21 | |
| 37 | Terlipressin 1mg plus 10ml diluent or 0point10mg oblicml 10 ml vial oblic Amp | as per title | 54 | vialamp | vibhu@181 | 21 | |
| 38 | Octreotide 0 point1 mg oblic ml Inj | as per title | 20 | ampvial | vibhu@181 | 21 | |
| 39 | Polidocanol 3 percent 2ml Inj | as per title | 10 | ampvial | vibhu@181 | 21 | |
| 40 | Ranitidine HCl 50 mg 2 ml Inj | as per title | 150 | ampvial | vibhu@181 | 21 | |
| 41 | Dicyclomine HCl 20mg Inj | as per title | 242 | ampvial | vibhu@181 | 21 | |
| 42 | Hyoscine Bromide Inj 20 mg oblicml 1ml Inj | as per title | 82 | ampvial | vibhu@181 | 21 | |
| 43 | Dinoprostone Gel 0point5mg in 3gm oblic2point5ml gel oblicSyringe | as per title | 50 | no | vibhu@181 | 21 | |
| 44 | Inj Human Insulin Analogue Rapid 100 IU Disposable Pen with 5 needles | as per title | 339 | pen | vibhu@181 | 21 | |
| 45 | Human Chorionic Gonadotrophin 2000 IU Inj | as per title | 150 | ampvial | vibhu@181 | 21 | |
| 46 | Pancuronium bromide 2 mg oblicml 2 ml Inj | as per title | 10 | ampvial | vibhu@181 | 21 | |
| 47 | Lignocaine 1 percent for intra-ocular use vial of 1 ml preservative free | as per title | 12 | ampvial | vibhu@181 | 21 | |
| 48 | Lignocaine Hyrochloride 4 percent topical solution bott of 30 ml | as per title | 12 | bott | vibhu@181 | 21 | |
| 49 | Natural Surfactanat 25 oblic80mg oblicml Inj | as per title | 5 | vial | vibhu@181 | 21 | |
| 50 | Haloperidol 5mg oblicml Inj | as per title | 25 | ampvial | vibhu@181 | 21 | |
| 51 | Dextrose 50 percent 25 ml Inj | as per title | 330 | ampvial | vibhu@181 | 21 | |
| 52 | Dextrose Inj 25 percent 25 ml Inj | as per title | 150 | ampvial | vibhu@181 | 21 | |
| 53 | Sodium Bicarbonate 7point5 percent amp of 10 ml | as per title | 156 | ampvial | vibhu@181 | 21 | |
| 54 | Meropenem 1 gm Inj | as per title | 462 | ampvial | vibhu@181 | 21 | |
| 55 | Vit B 12 500 mcg oblicml Inj | as per title | 322 | ampvial | vibhu@181 | 21 | |
| 56 | Multi Vit Inj IV 210 ml with minimum Thiamine B1 30mg Pyridoxine B6 30 mg ml | as per title | 222 | ampvial | vibhu@181 | 21 | |
| 57 | Dulaglutide 1point5 mg oblicml 0point5 ml PFS | as per title | 18 | pfs | vibhu@181 | 21 | |
| 58 | Human Insulin Analogue Glargine Recombinant DNA origin 450 IU oblic1 point5 pen | as per title | 60 | pfs | vibhu@181 | 21 | |
| 59 | Pheniramine Maleate 22point75 mg per ml Inj vial of 10 ml | as per title | 18 | ampvial | vibhu@181 | 21 | |
| 60 | Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj | as per title | 132 | ampvial | vibhu@181 | 21 | |
| 61 | Ampicillin 500 mg Inj | as per title | 10 | ampvial | vibhu@181 | 21 | |
| 62 | Benzyl penicillin 5 00 000 units inj | as per title | 12 | ampvial | vibhu@181 | 21 | |
| 63 | Amikacin Sulphate 250 mg oblic2 ml Inj | as per title | 532 | ampvial | vibhu@181 | 21 | |
| 64 | Cefoperazone Sodium 1 gm Inj | as per title | 120 | vial | vibhu@181 | 21 | |
| 65 | Inj Cefipime 1 mg | as per title | 120 | no | vibhu@181 | 21 | |
| 66 | Ceftazidime 1 gm Inj | as per title | 120 | ampvial | vibhu@181 | 21 | |
| 67 | Ceftriaxone 1 gm Inj | as per title | 860 | ampvial | vibhu@181 | 21 | |
| 68 | Cefuroxime 750 mg oblicVial Inj | as per title | 50 | ampvial | vibhu@181 | 21 | |
| 69 | Ticarcillin 3g plus Clavulanic Acid 100 mg Inj | as per title | 50 | ampvial | vibhu@181 | 21 | |
| 70 | Meropenem 500 mg Inj | as per title | 270 | ampvial | vibhu@181 | 21 | |
| 71 | Doxycycline Inj vial of 10 ml | as per title | 180 | vial | vibhu@181 | 21 | |
| 72 | Tropnin T test card | as per title | 300 | no | vibhu@181 | 21 | |
| 73 | BCG Vaccine | as per title | 18 | ampvial | vibhu@181 | 21 | |
| 74 | Hepatitis B Human Immunoglobulin HBIG | as per title | 12 | amp | vibhu@181 | 21 | |
| 75 | Tetanus Human Immunoglobulin | as per title | 6 | no | vibhu@181 | 21 | |
| 76 | Typhoid vi conjugate vaccine 2 point 5 ml | as per title | 180 | ampvial | vibhu@181 | 21 | |
| 77 | Cell culture rabies vaccine vial | as per title | 120 | dose | vibhu@181 | 21 | |
| 78 | Japanese Encephalitis Vaccine 0 point 5 ml | as per title | 108 | vial | vibhu@181 | 21 | |
| 79 | Tetanus Toxoid purified absorbed Vial of 5 ml 10 Doses | as per title | 108 | amp vial | vibhu@181 | 21 | |
| 80 | Human Rabies Immune Globulin 150 IU oblicml 2 ml Vial | as per title | 118 | vial | vibhu@181 | 21 | |
| 81 | Rabies Vaccine Vial of 1 ml | as per title | 60 | ml | vibhu@181 | 21 | |
| 82 | Anti D RHO Immunoglobulin Monoclonal Human vial of 300 oblic 350 mcg | as per title | 36 | ampvial | vibhu@181 | 21 | |
| 83 | Dantrolene Sodium 250 mg per Vial Inj | as per title | 30 | vial | vibhu@181 | 21 | |
| 84 | Inj Mephenteramine 10ml | as per title | 30 | vial | vibhu@181 | 21 | |
| 85 | Inj Ropivacaine hcl in dextrose 0 point 75 percent Amp of 4 ml | as per title | 12 | amp | vibhu@181 | 21 | |
| 86 | Mumps measles rubella vaccine MMR | as per title | 112 | amp | vibhu@181 | 21 | |
| 87 | Live Attenuated Hepatitis A Vaccine | as per title | 120 | amp | vibhu@181 | 21 | |
| 88 | Diptheria Tetanus and Acellular pertusis DTaP vaccine | as per title | 180 | amp | vibhu@181 | 21 | |
| 89 | Lignocaine HCL SOL 2 percent IV 50ML | as per title | 12 | no | vibhu@181 | 21 | |
| 90 | Inj Naloxone 4 mg per 10 ML | as per title | 12 | amp | vibhu@181 | 21 | |
| 91 | Inj Xylocard 2 pecent of 50 ML | as per title | 18 | vial | vibhu@181 | 21 |
Required Documents
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Corrigendum Updates
1 Update Update
Extended Deadline
22-May-2025, 2:00 pm
Opening Date
22-May-2025, 2:30 pm
Reverse Auction Schedule
Start
25-Jun-2025, 9:00 pm
End
27-Jun-2025, 10:00 am
Duration: 37 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 20-05-2025 12:52:05 | |
| 2 | ********** Under PMA | - | 21-05-2025 13:28:10 | |
| 3 | ********** Under PMA | - | 20-05-2025 17:18:15 | |
| 4 | ********** Under PMA | - | 22-05-2025 13:51:38 | |
| 5 | ********** Under PMA | - | 21-05-2025 13:52:25 | |
| 6 | ********** Under PMA | - | 21-05-2025 12:34:37 | |
| 7 | ********** Under PMA | - | 20-05-2025 13:59:44 | |
| 8 | ********** Under PMA | - | 19-05-2025 13:43:55 | |
| 9 | ********** Under PMA | - | 21-05-2025 13:04:54 | |
| 10 | ********** Under PMA | - | 22-05-2025 09:53:27 | |
| 11 | ********** Under PMA | - | 20-05-2025 23:23:41 | |
| 12 | ********** Under PMA | - | 21-05-2025 09:51:32 | |
| 13 | ********** Under PMA | - | 21-05-2025 13:59:57 | |
| 14 | ********** Under PMA | - | 19-05-2025 20:00:32 | |
| 15 | ********** Under PMA | - | 12-05-2025 17:39:51 | |
| 16 | ********** Under PMA | - | 20-05-2025 17:27:37 | |
| 17 | ********** Under PMA | - | 21-05-2025 10:25:55 | |
| 18 | ********** Under PMA | - | 17-05-2025 14:24:47 | |
| 19 | ********** Under PMA | - | 08-05-2025 14:28:42 | |
| 20 | ********** Under PMA | - | 21-05-2025 12:55:15 | |
| 21 | ********** Under PMA | - | 20-05-2025 17:11:07 |
Frequently Asked Questions
Key insights about ARUNACHAL PRADESH tender market
What are the eligibility requirements for GEM/2025/B/6151008?
The eligibility requirements for this tender necessitate that participants are registered entities with appropriate licenses and certifications for supplying pharmaceutical products. Bidder experience in the provision of sterile injectables is critical, showcasing a track record of delivery in high-stakes environments. Additionally, bidders must confirm their capability to meet the stringent dosing and delivery demands outlined in the tender.
Are there any specific certificates needed for submission?
Yes, bidders must include essential certificates associated with compliance to regulatory standards for pharmaceuticals. This includes certificates of analysis for each product offered, which validate the quality and sterility of the injection items. Vendors should also have administrative documents that substantiate their registration and any health and safety compliance needs.
What is the submission process for the tender proposal?
The submission process involves providing all required documentation through an electronic platform as indicated in the tender notice. Bidders must ensure that their proposals include the completed tender application form, detailed technical specifications, and the financial proposal. It's crucial to follow the operational guidelines to ensure a valid submission.
What are the criteria for price evaluation in this tender?
Price evaluation will focus on the total cost breakdown provided in the financial proposal, assessing value for money without compromising quality standards set by the Department of Military Affairs. Additional evaluation points may be awarded for compliant products that offer extended longevity or reduced adverse effects, ensuring the selection of the most cost-effective solutions for healthcare delivery.
Are there any benefits for MSEs or startups in this tender?
Yes, there are several benefits for Micro, Small, and Medium Enterprises (MSEs) and startups. These may include reduced pricing considerations, additional technical guidance during the bidding process, and favorable terms aimed at encouraging their participation. Furthermore, these provisions align with national policies promoting local content and procurement, particularly under the 'Make in India' initiative.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7751620.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS